Samuel Herschkowitz
Direktor/Vorstandsmitglied bei ACERUS PHARMACEUTICALS CORPORATION
Aktive Positionen von Samuel Herschkowitz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACERUS PHARMACEUTICALS CORPORATION | Direktor/Vorstandsmitglied | - | - |
NYU Langone Health
NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Serenity Pharmaceuticals LLC
Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Acerus Pharmaceuticals Corp., Serenity Pharmaceuticals LLC is a company that manufactures and distributes drugs. The company is based in Miami, FL. The company was founded by Samuel Herschkowitz. Samuel Herschkowitz has been the CEO since incorporation. Serenity Pharmaceuticals was acquired by Acerus Pharmaceuticals Corp. on March 07, 2022 for $44.30 million. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Gründer | - | - |
Karriereverlauf von Samuel Herschkowitz
Ehemalige bekannte Positionen von Samuel Herschkowitz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Serenity Pharmaceuticals Corp.
Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Vorstandsvorsitzender | 14.09.2009 | 01.02.2022 |
Vorsitzender | 01.01.2007 | 01.02.2022 | |
Gründer | 01.01.2007 | 01.02.2022 | |
PROSPECT PARK CAPITAL CORP. | Direktor/Vorstandsmitglied | - | 23.01.2020 |
Vorstandsvorsitzender | - | 23.01.2020 | |
Finanzdirektor/CFO | - | 23.10.2014 | |
DELCATH SYSTEMS, INC. | Direktor/Vorstandsmitglied | 01.01.1988 | 17.06.2007 |
Geschäftsführer | 01.01.1988 | 17.06.2007 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.1988 | 17.06.2007 |
Ausbildung von Samuel Herschkowitz
Syracuse University | Undergraduate Degree |
State University of New York at Downstate Medical Center | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Kanada | 3 |
Operativ
Director/Board Member | 3 |
Chief Executive Officer | 3 |
Chairman | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
DELCATH SYSTEMS, INC. | Health Technology |
PROSPECT PARK CAPITAL CORP. | Finance |
Private Unternehmen | 4 |
---|---|
NYU Langone Health
NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Technology Services |
Serenity Pharmaceuticals Corp.
Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Health Technology |
Serenity Pharmaceuticals LLC
Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Acerus Pharmaceuticals Corp., Serenity Pharmaceuticals LLC is a company that manufactures and distributes drugs. The company is based in Miami, FL. The company was founded by Samuel Herschkowitz. Samuel Herschkowitz has been the CEO since incorporation. Serenity Pharmaceuticals was acquired by Acerus Pharmaceuticals Corp. on March 07, 2022 for $44.30 million. | Health Technology |
Acerus Pharmaceuticals Corp.
Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
- Börse
- Insiders
- Samuel Herschkowitz
- Erfahrung